These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 15455349)

  • 1. C609T polymorphism of the NAD(P)H:quinone oxidoreductase I gene does not significantly affect susceptibility for esophageal adenocarcinoma.
    von Rahden BH; Stein HJ; Langer R; von Weyhern CW; Schenk E; Döring C; Siewert JR; Höfler H; Sarbia M
    Int J Cancer; 2005 Jan; 113(3):506-8. PubMed ID: 15455349
    [No Abstract]   [Full Text] [Related]  

  • 2. Association between NAD(P)H: quinone oxidoreductase 1 (NQ01) inactivating C609T polymorphism and adenocarcinoma of the upper gastrointestinal tract.
    Sarbia M; Bitzer M; Siegel D; Ross D; Schulz WA; Zotz RB; Kiel S; Geddert H; Kandemir Y; Walter A; Willers R; Gabbert HE
    Int J Cancer; 2003 Nov; 107(3):381-6. PubMed ID: 14506737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The NAD(P)H: quinone oxidoreductase 1 C609T polymorphism and susceptibility to esophageal cancer].
    Zhang JH; Li Y; Wang R; Sarbia M; Guo W; Wen DG; Wei LZ; Chen ZF; Kuang G; Zhang LW; He M; Wu ML; Wang SJ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Dec; 20(6):544-6. PubMed ID: 14669229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NAD(P)H:quinone oxidoreductase I C609T polymorphism modifies the risk of Barrett esophagus and esophageal adenocarcinoma.
    di Martino E; Hardie LJ; Wild CP; Gong YY; Olliver JR; Gough MD; Bird NC
    Genet Med; 2007 Jun; 9(6):341-7. PubMed ID: 17575500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and the risk of eight cancers for Japanese.
    Hamajima N; Matsuo K; Iwata H; Shinoda M; Yamamura Y; Kato T; Hatooka S; Mitsudomi T; Suyama M; Kagami Y; Ogura M; Ando M; Sugimura Y; Tajima K
    Int J Clin Oncol; 2002 Apr; 7(2):103-8. PubMed ID: 12018106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relationship between quinone oxidoreductase1 gene ns-cSNP and genetic susceptibility of esophageal cancer].
    Zhang WC; Yin LH; Pu YP; Liang GY; Hu X; Liu YZ; Cui YS
    Zhonghua Yu Fang Yi Xue Za Zhi; 2006 Sep; 40(5):324-7. PubMed ID: 17166422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Polymorphism of NAD(P)H dehydrogenase (quinone) 1 (NQO1) C 609 T and risk of esophageal neoplasm].
    Li Y; Zhang JH; Guo W; Wang R; Wen DG; Wei LZ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):731. PubMed ID: 15555408
    [No Abstract]   [Full Text] [Related]  

  • 8. NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and colorectal cancer predisposition in the ethnic Kashmiri population.
    Sameer AS; Shah ZA; Syeed N; Rasool R; Afroze D; Siddiqi MA
    Asian Pac J Cancer Prev; 2010; 11(1):209-13. PubMed ID: 20593958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genetic polymorphisms of NQO1, GSTT1, GSTM1 and susceptibility to chronic benzene poisoning].
    Chen Y; Li GL; Ji ZY; Xu JN; Wu CL
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2005 Feb; 23(1):1-5. PubMed ID: 15748501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NQO1 C609T polymorphism is associated with esophageal cancer risk among Chinese: a meta-analysis.
    Zhao HY; Gu Y; Yi YX
    Tumour Biol; 2014 Mar; 35(3):2199-203. PubMed ID: 24142529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Null association of NQO1 609C>T and NQO2 -3423G>A polymorphisms with susceptibility and prognosis of Esophageal cancer in north Indian population and meta-analysis.
    Umar M; Upadhyay R; Kumar S; Ghoshal UC; Mittal B
    Cancer Epidemiol; 2012 Dec; 36(6):e373-9. PubMed ID: 22770696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of the NAD(P)H:quinone oxidoreductase (NQO1) 609C->T polymorphism with lung cancer risk among male smokers.
    Lawson KA; Woodson K; Virtamo J; Albanes D
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2275-6. PubMed ID: 16172245
    [No Abstract]   [Full Text] [Related]  

  • 13. NQO1 C609T polymorphism and esophageal cancer risk: a HuGE review and meta-analysis.
    Yanling H; Yuhong Z; Wenwu H; Lei X; Mingwu C
    BMC Med Genet; 2013 Mar; 14():31. PubMed ID: 23497461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quinone oxidoreductase (NQO1) gene polymorphism may not confer a susceptibility to mood disorders.
    Pae CU; Yoon SJ; Patkar AA; Kim JJ; Lee C; Paik IH
    Psychiatry Res; 2007 Sep; 153(1):83-6. PubMed ID: 17644186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No associations between Parkinson's disease and polymorphisms of the quinone oxidoreductase (NQO1, NQO2) genes.
    Okada S; Farin FM; Stapleton P; Viernes H; Quigley SD; Powers KM; Smith-Weller T; Franklin GM; Longstreth WT; Swanson PD; Checkoway H
    Neurosci Lett; 2005 Mar; 375(3):178-80. PubMed ID: 15694256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the C609T polymorphism of NQO1 gene in South Croatian patients with hematological malignancies.
    Lozić B; Primorac D; Glavinić R; Samija RK; Zemunik T
    Coll Antropol; 2011 Jun; 35(2):385-8. PubMed ID: 21755707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No association between Helicobacter pylori seropositivity and ornithine decarboxylase (ODC) A317G polymorphism, and no modification by NAD(P)H:qinone oxidoreductase 1 (NQO1) C609T.
    Goto Y; Nishio K; Ishida Y; Kawai S; Osafune T; Naito M; Katsuda N; Hamajima N
    Nagoya J Med Sci; 2007 Jan; 69(1-2):17-22. PubMed ID: 17378176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased levels of NAD(P)H: quinone oxidoreductase 1 (NQO1) in pancreatic tissues from smokers and pancreatic adenocarcinomas: A potential biomarker of early damage in the pancreas.
    Lyn-Cook BD; Yan-Sanders Y; Moore S; Taylor S; Word B; Hammons GJ
    Cell Biol Toxicol; 2006 Mar; 22(2):73-80. PubMed ID: 16532285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of the NAD(P)H: quinone oxidoreductase C609T polymorphism and the risk of cervical cancer in Japanese subjects.
    Niwa Y; Hirose K; Nakanishi T; Nawa A; Kuzuya K; Tajima K; Hamajima N
    Gynecol Oncol; 2005 Feb; 96(2):423-9. PubMed ID: 15661231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of bladder cancer risk with an NAD(P)H:quinone oxidoreductase polymorphism in an ethnic Kashmiri population.
    Pandith AA; Khan NP; Shah ZA; Shah AM; Wani SM; Siddiqi MA
    Biochem Genet; 2011 Aug; 49(7-8):417-26. PubMed ID: 21253823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.